These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8605607)
1. Molybdenum and copper kinetics after tetrathiomolybdate injection in LEC rats: specific role of serum albumin. Suzuki KT; Ogra Y; Ohmichi M J Trace Elem Med Biol; 1995 Oct; 9(3):170-5. PubMed ID: 8605607 [TBL] [Abstract][Full Text] [Related]
2. Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats. Ogra Y; Ohmichi M; Suzuki KT J Trace Elem Med Biol; 1995 Oct; 9(3):165-9. PubMed ID: 8605606 [TBL] [Abstract][Full Text] [Related]
3. Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate. Ogra Y; Miyayama T; Anan Y J Inorg Biochem; 2010 Aug; 104(8):858-62. PubMed ID: 20427090 [TBL] [Abstract][Full Text] [Related]
4. Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats. Ogra Y; Suzuki KT J Inorg Biochem; 1998 Apr; 70(1):49-55. PubMed ID: 9661287 [TBL] [Abstract][Full Text] [Related]
5. Excretion of copper complexed with thiomolybdate into the bile and blood in LEC rats. Komatsu Y; Sadakata I; Ogra Y; Suzuki KT Chem Biol Interact; 2000 Feb; 124(3):217-31. PubMed ID: 10728780 [TBL] [Abstract][Full Text] [Related]
6. Removal and efflux of copper from Cu-metallothionein as Cu/tetrathiomolybdate complex in LEC rats. Ogra Y; Suzuki KT Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):196-204. PubMed ID: 7670851 [TBL] [Abstract][Full Text] [Related]
7. Removal of copper from the liver of Long-Evans Cinnamon (LEC) rats by tetrathiomolybdate (TTM) injection: the main excretion route is via blood, not bile. Sugawara N; Li D; Sugawara C Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):217-26. PubMed ID: 7994566 [TBL] [Abstract][Full Text] [Related]
8. Formation of copper-metallothionein/tetrathiomolybdate complex is the first step in removal of Cu from LEC rats. Suzuki KT; Ogra Y Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):187-95. PubMed ID: 7670850 [TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of the insoluble copper/tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate. Ogra Y; Chikusa H; Suzuki KT J Inorg Biochem; 2000 Jan; 78(2):123-8. PubMed ID: 10766335 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of tetrathiomolybdate on hepatic dysfunction occurring naturally in Long-Evans Cinnamon (LEC) rats: a bona fide animal model for Wilson's disease. Sugawara N; Lai YR; Sugawara C Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):177-87. PubMed ID: 10461684 [TBL] [Abstract][Full Text] [Related]
11. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease. Klein D; Arora U; Lichtmannegger J; Finckh M; Heinzmann U; Summer KH J Hepatol; 2004 Mar; 40(3):409-16. PubMed ID: 15123354 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rats. Ogra Y; Ohmichi M; Suzuki KT Toxicology; 1996 Jan; 106(1-3):75-83. PubMed ID: 8571404 [TBL] [Abstract][Full Text] [Related]
13. Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein. Suzuki KT Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):221-40. PubMed ID: 8556276 [TBL] [Abstract][Full Text] [Related]
14. Copper balance and ceruloplasmin in chronic hepatitis in a Wilson disease animal model, LEC rats. Komatsu Y; Ogra Y; Suzuki KT Arch Toxicol; 2002 Sep; 76(9):502-8. PubMed ID: 12242607 [TBL] [Abstract][Full Text] [Related]
15. Outputs of hepatic copper and cadmium stimulated by tetrathiomolybdate (TTM) injection in Long-Evans Cinnamon (LEC) rats pretreated with cadmium, and in Fischer rats pretreated with copper and cadmium. Lai YR; Sugawara N Toxicology; 1997 Jun; 120(1):47-54. PubMed ID: 9160108 [TBL] [Abstract][Full Text] [Related]
16. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease. George GN; Pickering IJ; Harris HH; Gailer J; Klein D; Lichtmannegger J; Summer KH J Am Chem Soc; 2003 Feb; 125(7):1704-5. PubMed ID: 12580588 [TBL] [Abstract][Full Text] [Related]
17. Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper. Ogra Y; Komada Y; Suzuki KT J Inorg Biochem; 1999 Jun; 75(3):199-204. PubMed ID: 10474204 [TBL] [Abstract][Full Text] [Related]
18. Copper in plasma reflects its status and subsequent toxicity in the liver of LEC rats. Rui M; Suzuki KT Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):335-46. PubMed ID: 9485527 [TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease. Plitz T; Boyling L Xenobiotica; 2019 Mar; 49(3):332-338. PubMed ID: 29460662 [TBL] [Abstract][Full Text] [Related]
20. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease. Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]